Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Perioperative management for muscle invasive bladder cancer (MIBC) includes neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy and risk-adapted adjuvant immunotherapy. More ...

Source: Getty Images The 2025 EAU guidelines provide updated insights into risk factors, diagnosis, classification, treatment, and follow-up of patients with muscle-invasive and metastatic bladder ...

Recurrences of low-, intermediate-, or high-/very high-risk tumors were again low, intermediate, or high risk in 74%, 62%, and 44% of cases, respectively. Recurrent non-muscle invasive bladder cancer ...

A man visited a hospital because of bladder discomfort, and his doctors discovered a remarkably large bladder stone.

Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...

Bladder Cancer e-Tumor Boards: Case 9: Metastatic Recurrent Urothelial Cancer This case highlights a patient who initially presented with an advanced stage upper tract urothelial tumor, and he ...

a, Schematic illustration of the workflow of the BLOOM assay. b,c, Mechanism of organogel messenger release from the biomarker-degradable bigel film (b) and solvatochromic dye transfer to the organic ...